Custom Compounded Therapy Market Report 2026

Custom Compounded Therapy Market Overview

• Custom Compounded Therapy market size has reached to $5.96 billion in 2025 • Expected to grow to $8.56 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Growing Demand For Personalized Medications Driving The Growth Of The Market Due To The Need For Tailored Treatments Based On Individual Patient Characteristics • Market Trend: Innovative Compounding Software Accelerates The Shift Toward Personalized Custom Therapies • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Custom Compounded Therapy Market?

Custom compounded therapy refers to the preparation of personalized medications by pharmacists, tailored to meet the specific needs of individual patients when standard treatments are not suitable. Its purpose is to provide customized dosages, formulations, or ingredients to improve treatment effectiveness, safety, and patient compliance. The main product types of custom compounded therapy are hormone replacement therapy, pain management, dermatology, nutritional supplements, and others. Hormone replacement therapy refers to the medical treatment that restores or supplements hormones in the body to relieve symptoms caused by hormone deficiencies or imbalances. These therapies are available in various types, including intravenous (IV) therapy, topical therapy, oral therapy, and subcutaneous therapy, with different formulations such as injectable, oral, and transdermal. They are used in various therapeutic applications, including oncology, neurology, cardiology, endocrinology, and pain management, with key end-users being hospitals, clinics, homecare settings, and specialty pharmacies.

What Is The Custom Compounded Therapy Market Growth Forecast?

The custom compounded therapy market size is expected to see strong growth in the next few years. It will grow to $8.56 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising demand for allergen-free formulations, expansion of home-based care models, growing regulatory clarity for compounding practices, increasing patient-centric healthcare delivery. Major trends in the forecast period include increasing adoption of personalized medication formulations, growing demand for patient-specific dosage customization, expansion of specialty compounding pharmacies, rising use of advanced compounding technologies, enhanced focus on treatment adherence.

Global Custom Compounded Therapy Market Segmentation

1) By Product Type: Hormone Replacement Therapy, Pain Management, Dermatology, Nutritional Supplements, Other Product Types 2) By Therapy Type: Intravenous (IV) Therapy, Topical Therapy, Oral Therapy, Subcutaneous Therapy 3) By Formulation: Injectable Formulation, Oral Formulation, Transdermal Formulation 4) By Therapeutic Applications: Oncology, Neurology, Cardiology, Endocrinology, Pain Management 5) By End-User: Hospitals, Clinics, Homecare Settings, Specialty Pharmacies Subsegments: 1) By Hormone Replacement Therapy: Estrogen Therapy, Testosterone Therapy, Progesterone Therapy, Thyroid Hormone Therapy, Combination Hormone Therapy 2) By Pain Management: Analgesics, Anti-Inflammatory Compounds, Muscle Relaxants, Topical Pain Relief, Opioid-Based Compounds 3) By Dermatology: Anti-Acne Formulations, Anti-Fungal Treatments, Anti-Aging Creams, Topical Steroids, Moisturizers And Emollients 4) By Nutritional Supplements: Vitamins, Minerals, Amino Acids, Probiotics, Herbal Supplements 5) By Other Product Types: Veterinary Compounds, Pediatric Formulations, Allergen-Free Medications, Specialty Compounds

What Is The Driver Of The Custom Compounded Therapy Market?

The growing demand for personalized medications is expected to propel growth of the custom compounded therapy market going forward. Personalized medication refers to the tailoring of medical treatment to the individual characteristics, needs, and preferences of each patient, often based on genetic, clinical, and lifestyle factors. The demand for personalized medication is rising due to its ability to improve treatment effectiveness and reduce adverse drug reactions by aligning therapies with individual patient profiles. Custom compounded therapy helps personalize medications by creating tailored formulations that match each patient’s unique needs, including specific doses, combinations, and delivery forms, ensuring more effective treatment and improved outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. food and drug administration approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the growing demand for personalized medications is driving the growth of the custom compounded therapy industry.

Key Players In The Global Custom Compounded Therapy Market

Major companies operating in the custom compounded therapy market are Hikma Pharmaceuticals PLC, Fagron N.V., Nephron Pharmaceuticals Corporation, Belmar Pharmacy LLC, Empower Clinic Services LLC, Medisca Pharmaceutique Inc., Central Admixture Pharmacy Services Inc., Wedgewood Connect LLC, AnazaoHealth Corporation, Wells Pharmacy Network LLC, Institutional Pharmacy Solutions Inc., Bennett Pharmaceuticals of America LLC, Bravado Pharmaceuticals LLC, Pencol Compounding Pharmacy Inc., Rx3 Compounding Pharmacy Inc., CareFirst Specialty Pharmacy LLC, Vertisis Custom Pharmacy LLC, FarmaKeio Pharmacy Network LLC, Professional Compounding Centers of America, Letco Medical LLC

Global Custom Compounded Therapy Market Trends and Insights

Major companies operating in the custom compounded therapy market are focusing on developing innovative solutions, such as next-generation compounding software, to meet the rising demand for personalized, precise, and efficient medication preparation. Compounding software streamlines the formulation process by integrating digital automation, quality control, and real-time data tracking, offering a more reliable and scalable alternative to traditional manual compounding methods. For instance, in October 2025, CurifyLabs, a Finland-based health-technology company, launched its Next-Generation Compounding Software, an advanced platform designed to enhance accuracy and efficiency in personalized medicine. The system supports automated formulation design, integrates with smart compounding devices, and incorporates built-in quality safeguards to reduce human error. It enables pharmacies and healthcare facilities to produce customized therapies more consistently, improves traceability through digital documentation, and accelerates preparation times. By delivering a fully digital compounding workflow, the solution significantly advances the capabilities of custom compounded therapy and supports safer, more individualized patient care.

What Are Latest Mergers And Acquisitions In The Custom Compounded Therapy Market?

In April 2024, Myonex, Inc., a US-based clinical trial supply company, acquired SaveWay Compounding Pharmacy, Inc. for an undisclosed amount. With this acquisition, Myonex aims to expand its clinical trial services across the U.S. by integrating SaveWay Compounding Pharmacy’s expertise in custom-compounded medications, strengthening its ability to deliver personalized drug formulations and ensuring reliable access to tailored therapies for both patients and clinical research needs. SaveWay Compounding Pharmacy Inc. is a US-based compounding pharmacy specializing in personalized sterile and non-sterile medications.

Regional Outlook

North America was the largest region in the custom compounded therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Custom Compounded Therapy Market?

The custom compounded therapy market consists of revenues earned by entities by providing services such as compounding pharmacy services, personalized consultations, prescription customization, and ongoing patient care support. The market value includes the value of related goods sold by the service provider or included within the service offering. The custom compounded therapy market also includes sales of topical creams, gels, sterile injectables, transdermal patches, and veterinary compounded medications. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Custom Compounded Therapy Market Report 2026?

The custom compounded therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the custom compounded therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.